Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01285570 · ClinicalTrials.gov registry record · Phase 3
Ulimorelin Study of Efficacy and Safety (ULISES 007)
A Phase 3 study of Gastrointestinal Dysmotility, sponsored by Tranzyme.
- Completed
- Registry status
- Phase 3
- Development phase
- 332
- Enrollment target
- 20
- Study locations
NCT01285570 is a Phase 3 study of Gastrointestinal Dysmotility that has completed, run by Tranzyme. The registered enrollment target is 332 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT01285570, a Phase 3 study of Gastrointestinal Dysmotility, has completed, sponsored by Tranzyme.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 332 participants
- Enrollment target
- 20
- Study locations
Study Summary
Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection.
Conditions Studied
Interventions
- DRUG Ulimorelin Intravenously (IV)
- DRUG 5% dextrose in water
Study Locations (20)
California
- Fountain Valley Regional Hospital - Fountain Valley
- Orange Coast Memorial Med. Ctr. - Fountain Valley
- USC, Colorectal Surgery Division - Los Angeles
- Cedars-Sinai Medical Center - Los Angeles
Florida
- Nature Coast Clinical Research - Inverness
- Jacksonville Center for Clinical Research - Jacksonville
- Pensacola Research Consultants - Pensacola
- Sunrise Clinical Research, Inc. - Sunrise
Oregon
- Bend Memorial Clinic - Bend
- Mt. Talbert Medical Offices - Clackamas
Colorado
- Denver VA Medical Center - Denver
Georgia
- ARS Clinical Trials - Powder Springs
Illinois
- So. Illinois Univ. School of Medicine - Springfield
Kentucky
- Univ. of Louisville, Dept. of Surgery - Louisville
Massachusetts
- UMass Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01285570
The ClinicalTrials.gov registry entry for NCT01285570 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tranzyme, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastrointestinal Dysmotility appearing as the primary indexed condition, and to 2 interventions - of which Ulimorelin Intravenously (IV) is the first listed.
NCT01285570 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Oregon.
Frequently Asked Questions
What is clinical trial NCT01285570 about?
NCT01285570 is a clinical study titled "Ulimorelin Study of Efficacy and Safety (ULISES 007)". Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection.
What is the current status of trial NCT01285570?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 332 participants. The study started on 2011-01. Estimated completion is 2012-01.
What conditions does trial NCT01285570 study?
This clinical trial studies the following conditions: Gastrointestinal Dysmotility.
What interventions are being tested in trial NCT01285570?
The interventions under investigation include: Ulimorelin Intravenously (IV) (DRUG), 5% dextrose in water (DRUG).
Who is sponsoring clinical trial NCT01285570?
This trial is sponsored by Tranzyme, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01285570 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Dysmotility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.